Cargando…

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial

BACKGROUND: The Cytosponge is a cell-collection device, which, coupled with a test for trefoil factor 3 (TFF3), can be used to diagnose Barrett’s oesophagus, a precursor condition to oesophageal adenocarcinoma. BEST3, a large pragmatic, randomised, controlled trial, investigated whether offering the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghimire, Bhagabati, Landy, Rebecca, Maroni, Roberta, Smith, Samuel G., Debiram-Beecham, Irene, Sasieni, Peter D., Fitzgerald, Rebecca C., Rubin, Greg, Walter, Fiona M., Waller, Jo, Offman, Judith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832657/ https://www.ncbi.nlm.nih.gov/pubmed/36627580 http://dx.doi.org/10.1186/s12876-022-02630-1

Ejemplares similares

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial
por: Maroni, Roberta, et al.
Publicado: (2022)

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
por: Fitzgerald, Rebecca C, et al.
Publicado: (2020)

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
por: Offman, Judith, et al.
Publicado: (2018)

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2017)

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
por: di Pietro, Massimiliano, et al.
Publicado: (2020)

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data
por: Swart, Nicholas, et al.
Publicado: (2021)

Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach
por: Hadjinicolaou, ANDREAS V., et al.
Publicado: (2022)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
por: Pilonis, Nastazja Dagny, et al.
Publicado: (2022)

Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress
por: Fitzgerald, Rebecca C., et al.
Publicado: (2017)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
por: Jones, Christopher M., et al.
Publicado: (2022)

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study
por: Xu, Yiwang, et al.
Publicado: (2019)

Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples
por: Masqué-Soler, Neus, et al.
Publicado: (2022)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study
por: Offman, Judith, et al.
Publicado: (2021)

Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study
por: Katzka, David A, et al.
Publicado: (2017)

Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
por: Masuda, Mia Y., et al.
Publicado: (2022)

Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
por: Offman, Judith, et al.
Publicado: (2018)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial
por: Landy, Rebecca, et al.
Publicado: (2021)

Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women
por: Landy, Rebecca, et al.
Publicado: (2022)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

A88 EVALUATING THE ACCEPTABILITY AND EFFICACY OF CYTOSPONGE FOR BARRETT'S ESOPHAGUS: A SINGLE CENTRE CROSS-SECTIONAL STUDY
por: Alqattan, A E, et al.
Publicado: (2023)

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

Years of life lost due to cancer in the United Kingdom from 1988 to 2017
por: Ahmad, Amar S., et al.
Publicado: (2023)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review
por: Lim, Anita WW, et al.
Publicado: (2016)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Cervical cytology and the diagnosis of cervical cancer in older women
por: Landy, Rebecca, et al.
Publicado: (2015)

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries
por: Castanon, Alejandra, et al.
Publicado: (2017)

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study
por: Kadri, Sudarshan R, et al.
Publicado: (2010)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study
por: Castanon, Alejandra, et al.
Publicado: (2014)

Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting
por: Middleton, Daniel R. S., et al.
Publicado: (2020)

Vulnerability to HIV infection among female drug users in Kathmandu Valley, Nepal: a cross-sectional study
por: Ghimire, Bhagabati, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_csmc0licm3b294i5nilugvnv2f